Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.
Standard
Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate. / Janka-Schaub, Gritta; Winkler, K; Juergens, H; Goebel, U.
In: Haematol Blood Transfus, Vol. 30, 1987, p. 456-460.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.
AU - Janka-Schaub, Gritta
AU - Winkler, K
AU - Juergens, H
AU - Goebel, U
PY - 1987
Y1 - 1987
M3 - SCORING: Zeitschriftenaufsatz
VL - 30
SP - 456
EP - 460
JO - BLOOD TRANSFUS-ITALY
JF - BLOOD TRANSFUS-ITALY
SN - 1723-2007
ER -